Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications
about
Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatmentPlasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.The perception of trauma patients from social support in adjustment to lower-limb amputation: a qualitative study.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Response to comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.Fetal environment, epigenetics, and pediatric renal disease.Markers of endothelial dysfunction and inflammation predict progression of diabetic nephropathy in African Americans with type 1 diabetesGenome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin.Fine tuning gene expression: the epigenome.Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC CohortHigh levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over timeProspective association between inflammatory markers and progression of coronary artery calcification in adults with and without type 1 diabetesBaseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjectsNetwork of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (the FinnDiane Study).Inflammation as a Therapeutic Target for Diabetic Neuropathies.Macrovascular angiopathy in children and adolescents with type 1 diabetes.Diabetic dyslipidemia or 'diabetes lipidus'?The effect of RAAS blockade on the progression of diabetic nephropathy.Insulin resistance and hyperglycaemia in cardiovascular disease development.High glucose increases the formation and pro-oxidative activity of endothelial microparticles.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Clinical and biochemical predictors of increased carotid intima-media thickness in overweight and obese adolescents with type 2 diabetes.Pathophysiological Fundamentals of Diabetic Cardiomyopathy.Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes.Elevation in blood flow and shear rate prevents hyperglycemia-induced endothelial dysfunction in healthy subjects and those with type 2 diabetes.High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes.Increased serum kallistatin levels in type 1 diabetes patients with vascular complicationsTime for a victory lap or time to raise the levees: a perspective on complication reduction and new-onset diabetes.Physical activity and dietary habits during pregnancy: effects on glucose tolerance.Life-long physical activity restores metabolic and cardiovascular function in type 2 diabetes.Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults.Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.Adolescents and young adults with newly diagnosed Type 2 diabetes demonstrate greater carotid intima-media thickness than those with Type 1 diabetes.Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyPatients with Type 1 diabetes consuming alcoholic spirits have an increased risk of microvascular complicationsThe Role of Transforming Growth Factor-Beta in Diabetic Nephropathy
P2860
Q33610151-497BF59C-1F45-4A01-8B86-45D9312F3339Q34053743-DE853A9C-8204-4073-B849-ABD2241456FAQ34131385-AB20FCFE-94B8-46C9-82C1-7262053C3190Q34219439-5EBE32FA-7451-41BA-97CC-CA5F9C7BEE96Q34278935-5D409129-ABDC-4B9A-BE0C-A2B81D7378B3Q34625920-58C88B1A-24D5-4EBD-86C3-4AB366656883Q34682583-473DAA08-FBC8-47E2-8C4C-B99183FFB35AQ35138418-4FB5E1E0-B518-47EF-9A91-58F5E26211D0Q35188187-1B4589F0-CF39-4A6E-9AD7-9DA6A24D716DQ35769521-E0B989C0-EAD4-4C93-BFE5-CFCDD70DA90EQ36318280-B8CDADF1-E73F-4383-9643-8ACDF5F6E0B6Q36562533-84746526-6B1F-4453-9D12-C7B838600F4BQ36820594-FD96E409-7B35-4DB8-B5AF-27BD6C1665DDQ36868327-53C8D0CB-E093-450E-8F2D-4197488FE928Q36942224-0C80A753-0580-4CC4-A25F-9E9484C78870Q37022573-28949636-058A-4AAD-B506-A9EB8629F709Q37392018-4E75121D-98FD-4061-988D-BAAF57A4D3ACQ37450547-A10E9D53-AEEF-464F-BAB3-3CFCC0981AC5Q37857087-FC152647-6091-4BF2-8AAB-BD5B7C953ADDQ37857864-060CA1CB-4EE8-4089-937E-76DC3AAEA9C1Q38168046-8C1B7264-B6E5-47FC-97AD-6595FCD9F4C7Q38198953-22FCB7EC-41EF-4BF3-9D4D-47DA97763D89Q38432562-D5DDC94C-402D-4DF3-AEC5-DA72CBA851A1Q38936622-3357B8BA-7D81-438E-B04C-7D0FD2D61685Q39146317-0366074B-06F3-49C8-B0C9-A0DCE47D3F48Q39195672-069A4BCD-F253-4A5B-B113-FB5B474C8391Q41549542-02F4D263-7A3A-439C-9936-5985A3F6F69FQ41576187-BB2C0117-0B58-41BD-9170-7A169366E545Q41712436-068CF3D2-D6EF-4B0E-8033-784FCB9AE11EQ42034969-C38F6360-E45C-4D74-9E89-826A6DA538E5Q42874795-9F542CA1-4F75-4CD5-A813-B76C1DB3E65AQ43119938-44728D85-0260-496A-B2EB-7C7EA41A750FQ44316306-6735EBAA-BD3E-4F13-ABC2-0C490B4B057BQ46254739-9384AF2B-C95B-4174-A5A4-657DDAEEF896Q47423928-7C106B07-2D9C-412A-90E0-CDC7034AFC6FQ51333003-1BA81DDD-421E-4363-8F3F-6DFF2B174793Q51743713-327256A8-8976-4517-9A66-0359C701E0A1Q57274310-D1BCC16C-45B5-42EB-B762-7356226A64CCQ57303525-D650217F-0BE3-49C7-B676-98E0A21E4A2BQ59048778-4108832C-726F-468D-9D20-180CB1556839
P2860
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Risk factors related to inflam ...... nd macrovascular complications
@en
type
label
Risk factors related to inflam ...... nd macrovascular complications
@en
prefLabel
Risk factors related to inflam ...... nd macrovascular complications
@en
P2093
P2860
P356
P1433
P1476
Risk factors related to inflam ...... nd macrovascular complications
@en
P2093
Diabetes Control and Complicat ...... mplications Cohort Study Group
Gabriel Virella
Maria F Lopes-Virella
Miran Jaffa
Richard L Klein
Rickey E Carter
Timothy J Lyons
W Timothy Garvey
P2860
P304
P356
10.2337/DC08-0659
P407
P577
2008-07-15T00:00:00Z